U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Tirzepatide Injection
Status: Currently in Shortage
»Date first posted: 12/15/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Company (Reverified 03/22/2023)

Company Contact Information:
800-545-5979

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg/0.5mL (NDC 0002-1495-80) Available Demand increase for the drug
10mg/0.5mL (NDC 0002-1471-80) Available Demand increase for the drug
2.5mg/0.5mL (NDC 0002-1506-80) Available Demand increase for the drug
7.5mg/0.5mL (NDC 0002-1484-80) Available Demand increase for the drug
12.5mg/0.5mL (NDC 0002-1460-80) Available Demand increase for the drug
15mg/0.5mL (NDC 0002-1457-80) Available Demand increase for the drug
Back to Top